U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. DSEO LLC - 04/18/2017
  1. Warning Letters

CLOSEOUT LETTER

DSEO LLC


Recipient:
DSEO LLC

United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

 

 
5001 Campus Drive
College Park, MD 20740 

APR 18, 2017

Armando Lopez
DSEO LLC
11651 Sterling Ave.
Suite L
Riverside, CA 92503-7115

Dear Mr. Lopez:

The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter 447399, issued April 24, 2015. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Latasha A Robinson
Branch Chief
Dietary Supplement and Labeling
     Assessment Branch
Division of Enforcement
Office of Compliance
Center for Food Safety and Applied Nutrition

Back to Top